Finance

Lists
Why is ZNTL down 2,50%?
Dive Deeper
ZNTL:NASDAQ
Zentalis Pharmaceuticals Inc
2,54 US$
-2,50%
(-0,065) 1D
2 ოქტ, 15:18:17 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZNTL...
Open
2,64 US$
High
2,65 US$
Low
2,53 US$
Mkt. cap
240,00 მლნ.
Avg. vol.
1,11 მლნ.
Volume
892,61 ათ.
52-wk high
6,95 US$
52-wk low
1,21 US$
EPS
-1,96 US$
Beta
1,93
Shares outstanding
94,67 მლნ.
No. of employees
106
Open
2,64 US$
High
2,65 US$
Low
2,53 US$
Mkt. cap
240,00 მლნ.
Avg. vol.
1,11 მლნ.
Volume
892,61 ათ.
52-wk high
6,95 US$
52-wk low
1,21 US$
EPS
-1,96 US$
Beta
1,93
Shares outstanding
94,67 მლნ.
No. of employees
106
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
18 საათის წინ
Wells Fargo sets USD 5.00 target for Zentalis Pharmaceuticals stock
Investing.com
Investing.com
·
20 საათის წინ
Form 4 Zentalis Pharmaceuticals Llc For: 1 October By Investing.com
About Zentalis Pharmaceuticals Inc
CEO-
Employees106
Founded2014
Headquarters-
Sector-
Websitezentalis.com
Analyst ratings
Based on 7 analysts giving stock ratings to ZNTL in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ZNTL in the last 3 months.
Highest
Current 2,54 US$
11,00 US$ (+333,07%)
Average
8,17 US$ (+221,65%)
Lowest
5,00 US$ (+96,85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yanan Zhu
Wells Fargo
Hold
Maintained
5,00 US$
+96,9%
09/29/2026
Matt Phipps
William Blair
Buy
Initiated
-
-
09/15/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
8,00 US$
+215%
08/11/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
5,00 US$
+96,9%
08/07/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
10,00 US$
+293,7%
08/07/2026
Michael Schmidt
Guggenheim
Buy
Maintained
10,00 US$
+293,7%
08/07/2026
Michael King
Rodman & Renshaw
Buy
Initiated
11,00 US$
+333,1%
07/23/2026
Jay Olson
Oppenheimer
Buy
Initiated
9,00 US$
+254,3%
06/15/2026
Unknown Analyst
Wedbush
Hold
Maintained
4,00 US$
+57,5%
05/13/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
9,00 US$
+254,3%
05/13/2026
Eva Fortea Verdejo
Wells Fargo
Hold
Reiterated
5,00 US$
+96,9%
05/13/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,95 მლნ.
30,69 მლნ.
28,72 მლნ.
35,16 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,78 მლნ.
3,77 მლნ.
9,14 მლნ.
9,23 მლნ.
Operating expense
33,73 მლნ.
34,46 მლნ.
37,86 მლნ.
44,39 მლნ.
Total operating expenses
33,73 მლნ.
34,46 მლნ.
37,86 მლნ.
44,39 მლნ.
Operating income
-33,73 მლნ.
-34,46 მლნ.
-37,86 მლნ.
-44,39 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-26,69 მლნ.
-34,77 მლნ.
-35,23 მლნ.
-42,15 მლნ.
EBT excluding unusual items
-26,69 მლნ.
-34,12 მლნ.
-35,23 მლნ.
-42,15 მლნ.
Income tax expense
-
442,00 ათ.
120,00 ათ.
138,00 ათ.
Effective tax rate
-
-1,27%
-0,34%
-0,33%
Other operating expenses
-
-
-
-
Net income
-26,69 მლნ.
-35,22 მლნ.
-35,35 მლნ.
-42,29 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,37
-0,49
-0,50
-0,59
Interest and investment income
7,04 მლნ.
338,00 ათ.
2,62 მლნ.
2,24 მლნ.
Interest expense
-
-
-
-
Net interest expenses
7,04 მლნ.
338,00 ათ.
2,62 მლნ.
2,24 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,57 მლნ.
-34,30 მლნ.
-37,70 მლნ.
-44,24 მლნ.
Gain or loss from assets sale
-103,00 ათ.
-26,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები